Thalio, all I can say is that I am not a basher here. I have no sore points against CYGX. I like and believe in its science even though I understand that science may not success in commercialization. I like the solid results in the mainstream publications and universities. I like the makeup of the BOD/SAD and key employees. I am a little fearful of the financial stability.
The only problem with CYGX so far in all the DD I've done is Phanuel.
It is my hope that members of this board can discover more on this Phanuel and share it here.